National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

3'-deoxy-3'-[18F]fluorothymidine
A radioconjugate consisting of a thymidine analogue radiolabeled with fluorine F 18, a positron emitting isotope. Phosphorylated by S-phase-specific thymidine kinase 1, 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) is trapped intracellularly by entering the salvage pathway of DNA synthesis without incorporation into DNA. 18F-FLT serves a marker of tumor cell proliferation for imaging with positron emission tomography (PET); as a marker of proliferation rather than metabolism, it is more specific to tumor tissue than 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG). This agent is metabolically stable, accumulates in the normal bone marrow and the liver, and does not cross the blood-brain barrier. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:18F-FLT

Previous:131I-TM-601, 18F-FHBG, 18F-fluoromethylcholine, 18F-fluoromisonidazole, 2-methoxyestradiol
Next:3,4-methylenedioxymethamphetamine, 3-deazauridine, 4'-iodo-4'-deoxydoxorubicin, 4-hydroxytamoxifen, 4-nitroestrone 3-methyl ether